Factors associated with long-term hypnotics use in depression
Open Access
- 17 February 2026
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 403, 121415
Abstract
No abstract availableKeywords
Funding Information
- Karolinska Institutet
- Janssen Pharmaceutica (5-63/2015)
This publication has 43 references indexed in Scilit:
- New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patientsInternational Journal of Methods in Psychiatric Research, 2024
- Trends in Use of Melatonin Supplements Among US Adults, 1999-2018JAMA, 2022
- Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in FinlandJAMA Network Open, 2020
- Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysisOsteoporosis International, 2018
- Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014JAMA Psychiatry, 2017
- Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D dataPsychopharmacology, 2017
- Association between use of benzodiazepines and risk of fractures: a meta-analysisOsteoporosis International, 2013
- Long‐term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugsPharmacoepidemiology and Drug Safety, 2011
- Treatment of major depressive disorder in the Finnish general populationDepression and Anxiety, 2009
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006